Page last updated: 2024-11-11
u 104067
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Description
U 104067: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 9888401 |
CHEMBL ID | 335071 |
SCHEMBL ID | 7990699 |
MeSH ID | M0253233 |
Synonyms (11)
Synonym |
---|
CHEMBL335071 |
SCHEMBL7990699 |
u-104067 |
u 104067 |
unii-59ij4gv3fc |
172035-69-7 |
9h-pyrimido(4,5-b)indole, 9-(2-(4-morpholinyl)ethyl)-2,4-di-1-pyrrolidinyl- |
9-(2-(4-morpholinyl)ethyl)-2,4-di-1-pyrrolidinyl-9h-pyrimido(4,5-b)indole |
59IJ4GV3FC , |
u-104067 free base |
4-[2-(2,4-dipyrrolidin-1-ylpyrimido[4,5-b]indol-9-yl)ethyl]morpholine |
Research Excerpts
Dosage Studied
Excerpt | Relevance | Reference |
---|---|---|
" Experiment 2 demonstrated a significant neuroprotective effect of 10 and 30 mg/kg U-104067F using the same dosing schedule." | ( Two novel pyrrolopyrimidine lipid peroxidation inhibitors U-101033E and U-104067F protect facial motor neurons following neonatal axotomy. Hall, ED; Oostveen, JA; Smith, SL, 1996) | 0.29 |
" Male Mongolian gerbils were dosed with U-101033E (1." | ( Neuroprotective effects of the novel brain-penetrating pyrrolopyrimidine antioxidants U-101033E and U-104067F against post-ischemic degeneration of nigrostriatal neurons. Andrus, PK; Fleck, TJ; Hall, ED; Oostveen, JA, 1997) | 0.3 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (16)
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID132861 | The compound was tested for spinal neuroprotection in mouse. | 1995 | Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21 | Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity. |
AID19550 | The compound was tested for terminal half-life pharmacokinetic parameter in the male Sprague-Dawley rat. | 1995 | Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21 | Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity. |
AID185137 | The compound was tested for inhibition of lung eosinophilia in rat at 10 mg/kg/day, po | 1995 | Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21 | Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity. |
AID22411 | The compound was tested for steady state volume of distribution pharmacokinetic parameter in the male Sprague-Dawley rat. | 1995 | Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21 | Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity. |
AID133387 | The compound was tested for inhibition of lung eosinophilia in mouse at 10 mg/kg/day, po | 1995 | Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21 | Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity. |
AID20734 | The compound was tested for tmax value pharmacokinetic parameter in the male Sprague-Dawley rat. | 1995 | Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21 | Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity. |
AID89974 | The compound was tested for cytoprotective effect against the human astroglial cells. | 1995 | Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21 | Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity. |
AID14480 | The compound was tested for Cmax value pharmacokinetic parameter in the male Sprague-Dawley rat. | 1995 | Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21 | Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity. |
AID14038 | Oral bioavailability in rat (Sprague-Dawley) (male) | 1995 | Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21 | Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity. |
AID185141 | The compound was tested for inhibition of lung eosinophilia in rat at 3 mg/kg/day, po; Not Tested | 1995 | Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21 | Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity. |
AID133389 | The compound was tested for inhibition of lung eosinophilia in mouse at 30 mg/kg/day, po | 1995 | Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21 | Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity. |
AID16282 | The compound was tested for systemic clearance pharmacokinetic parameter in the male Sprague-Dawley rat. | 1995 | Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21 | Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity. |
AID185139 | The compound was tested for inhibition of lung eosinophilia in rat at 30mg/kg/day, po | 1995 | Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21 | Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity. |
AID133388 | The compound was tested for inhibition of lung eosinophilia in mouse at 3 mg/kg/day, po | 1995 | Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21 | Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity. |
AID137600 | The compound was evaluated for increase in neurological status at 1 hr post head injury using a simple grip test in mouse; Not Determined | 1995 | Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21 | Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity. |
AID195557 | The compound was tested for inhibition of [Fe2+]-induced MDA formation in rat brain homogenate; Not Determined | 1995 | Journal of medicinal chemistry, Oct-13, Volume: 38, Issue:21 | Synthesis of novel 2,4-diaminopyrrolo-[2,3-d]pyrimidines with antioxidant, neuroprotective, and antiasthma activity. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |